86 related articles for article (PubMed ID: 9219845)
1. Protection of 5alpha-dihydrotestosterone against TGF-beta-induced apoptosis in FaO cells and induction of mitosis in HepG2 cells.
Lim IK; Joo HJ; Choi KS; Sueoka E; Lee MS; Ryu MS; Fujiki H
Int J Cancer; 1997 Jul; 72(2):351-5. PubMed ID: 9219845
[TBL] [Abstract][Full Text] [Related]
2. Dihydrotestosterone enhances transforming growth factor-beta-induced apoptosis in hormone-sensitive prostate cancer cells.
Bruckheimer EM; Kyprianou N
Endocrinology; 2001 Jun; 142(6):2419-26. PubMed ID: 11356690
[TBL] [Abstract][Full Text] [Related]
3. Effects of transforming growth factor beta-1 and all-trans-retinoic acid on androgen-induced development of neonatal mouse bulbourethral glands in vitro.
Tanji N; Rahman SA; Terada N; Yokoyama M; Cunha GR
Int J Androl; 2000 Apr; 23(2):58-64. PubMed ID: 10762431
[TBL] [Abstract][Full Text] [Related]
4. ICE-like protease (caspase) is involved in transforming growth factor beta1-mediated apoptosis in FaO rat hepatoma cell line.
Choi KS; Lim IK; Brady JN; Kim SJ
Hepatology; 1998 Feb; 27(2):415-21. PubMed ID: 9462639
[TBL] [Abstract][Full Text] [Related]
5. Role of dihydrotestosterone (DHT) on TGF-β1 signaling pathway in epithelial ovarian cancer cells.
Kohan-Ivani K; Gabler F; Selman A; Vega M; Romero C
J Cancer Res Clin Oncol; 2016 Jan; 142(1):47-58. PubMed ID: 26091707
[TBL] [Abstract][Full Text] [Related]
6. Effects of gonadal and adrenal androgens in a novel androgen-responsive human osteoblastic cell line.
Hofbauer LC; Hicok KC; Khosla S
J Cell Biochem; 1998 Oct; 71(1):96-108. PubMed ID: 9736458
[TBL] [Abstract][Full Text] [Related]
7. Modulation of sensitivity to transforming growth factor-beta 1 (TGF-beta 1) and the level of type II TGF-beta receptor in LNCaP cells by dihydrotestosterone.
Kim IY; Zelner DJ; Sensibar JA; Ahn HJ; Park L; Kim JH; Lee C
Exp Cell Res; 1996 Jan; 222(1):103-10. PubMed ID: 8549651
[TBL] [Abstract][Full Text] [Related]
8. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
Zhu ML; Partin JV; Bruckheimer EM; Strup SE; Kyprianou N
Prostate; 2008 Feb; 68(3):287-95. PubMed ID: 18163430
[TBL] [Abstract][Full Text] [Related]
9. Bcl-2 antagonizes the combined apoptotic effect of transforming growth factor-beta and dihydrotestosterone in prostate cancer cells.
Bruckheimer EM; Kyprianou N
Prostate; 2002 Oct; 53(2):133-42. PubMed ID: 12242728
[TBL] [Abstract][Full Text] [Related]
10. Role of MAP kinases and their cross-talk in TGF-beta1-induced apoptosis in FaO rat hepatoma cell line.
Park HJ; Kim BC; Kim SJ; Choi KS
Hepatology; 2002 Jun; 35(6):1360-71. PubMed ID: 12029621
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of transforming growth factor-beta 1 on androgen-induced development of neonatal mouse seminal vesicles in vitro.
Tanji N; Tsuji M; Terada N; Takeuchi M; Cunha GR
Endocrinology; 1994 Mar; 134(3):1155-62. PubMed ID: 8119154
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of transforming growth factor beta receptors by androgen in ovarian cancer cells.
Evangelou A; Jindal SK; Brown TJ; Letarte M
Cancer Res; 2000 Feb; 60(4):929-35. PubMed ID: 10706107
[TBL] [Abstract][Full Text] [Related]
13. The role of transforming growth factor-beta1, -beta2, and -beta3 in androgen-responsive growth of NRP-152 rat prostatic epithelial cells.
Lucia MS; Sporn MB; Roberts AB; Stewart LV; Danielpour D
J Cell Physiol; 1998 May; 175(2):184-92. PubMed ID: 9525477
[TBL] [Abstract][Full Text] [Related]
14. EGF- and CPA-induced mitogenic stimuli are differentially down-regulated by TGF-beta1 in cultured rat hepatocytes.
Fasciati R; Maier P
Carcinogenesis; 1997 May; 18(5):911-7. PubMed ID: 9163675
[TBL] [Abstract][Full Text] [Related]
15. The conventional transforming growth factor-beta (TGF-beta) receptor type I is not required for TGF-beta 1 signaling in a human prostate cancer cell line, LNCaP.
Kim IY; Zelner DJ; Lee C
Exp Cell Res; 1998 May; 241(1):151-60. PubMed ID: 9633523
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta1 is a mediator of androgen-regulated growth arrest in an androgen-responsive prostatic cancer cell line, LNCaP.
Kim IY; Kim JH; Zelner DJ; Ahn HJ; Sensibar JA; Lee C
Endocrinology; 1996 Mar; 137(3):991-9. PubMed ID: 8603613
[TBL] [Abstract][Full Text] [Related]
17. Regulation of rat prostate stromal cell myodifferentiation by androgen and TGF-beta1.
Gerdes MJ; Larsen M; Dang TD; Ressler SJ; Tuxhorn JA; Rowley DR
Prostate; 2004 Feb; 58(3):299-307. PubMed ID: 14743470
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferators induce apoptosis and decrease DNA synthesis in hepatoma cell lines.
Goll V; Viollon-Abadie C; Nicod L; Richert L
Hum Exp Toxicol; 2000 Mar; 19(3):193-202. PubMed ID: 10889518
[TBL] [Abstract][Full Text] [Related]
19. Androgenic control of transforming growth factor-beta signaling in prostate epithelial cells through transcriptional suppression of transforming growth factor-beta receptor II.
Song K; Wang H; Krebs TL; Kim SJ; Danielpour D
Cancer Res; 2008 Oct; 68(19):8173-82. PubMed ID: 18829577
[TBL] [Abstract][Full Text] [Related]
20. Inhibition by dexamethasone of transforming growth factor beta1-induced apoptosis in rat hepatoma cells: a possible association with Bcl-xL induction.
Yamamoto M; Fukuda K; Miura N; Suzuki R; Kido T; Komatsu Y
Hepatology; 1998 Apr; 27(4):959-66. PubMed ID: 9537434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
